[Development of the ultra-fine size reduction method of slightly soluble medicinal crystals. IV. Enhanced bioavailability of oxolinic acid by ultra-fine size reduction].
D000818:Animals; D001682:Biological Availability; D003460:Crystallization; D004285:Dogs; D007408:Intestinal Absorption; D008297:Male; D010093:Oxolinic Acid / Q000378:metabolism*; D010316:Particle Size; D012995:Solubility
D010093:Oxolinic Acid